Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in Nuklearmedizin

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    June 2018
  1. CHOI BW, Won Kim H, Jeon JC, Kang S, et al
    Nodular fasciitis mimicking malignant soft tissue tumor in an infant, with 18F-FDG PET/CT findings: A case report.
    Nuklearmedizin. 2018;57:N29-N31.
    PubMed     Text format    


  2. STANZEL S, Pernthaler B, Schwarz T, Bjelic-Radisic V, et al
    Diagnostic and prognostic value of additional SPECT/CT in sentinel lymph node mapping in breast cancer patients.
    Nuklearmedizin. 2018;57:92-99.
    PubMed     Text format     Abstract available


  3. KOTZERKE J, Bohmer D, Schlomm T, Maurer T, et al
    [PSMA-PET/CT has to be performed in every patient with biochemical recurrence following radical prostatectomy for early tumor detection].
    Nuklearmedizin. 2018;57:69-73.
    PubMed     Text format     Abstract available


    April 2018
  4. SCHOEN M, Braun T, Manava P, Ludwigs S, et al
    Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Nuklearmedizin. 2018;57:50-55.
    PubMed     Text format     Abstract available


    February 2018
  5. SCHAEFER WM, Knollmann D, Avondo J, Meyer A, et al
    Volume/perfusion ratio from lung SPECT/CT.
    Nuklearmedizin. 2018;57:31-34.
    PubMed     Text format     Abstract available


  6. DRAGER DL, Heuschkel M, Protzel C, Erbersdobler A, et al
    [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Nuklearmedizin. 2018;57:26-30.
    PubMed     Text format     Abstract available


  7. BOY C, Poeppel T, Kotzerke J, Krause BJ, et al
    [Somatostatin receptor PET/CT (SSTR-PET/CT)].
    Nuklearmedizin. 2018;57:4-17.
    PubMed     Text format     Abstract available


    July 2017
  8. ZHANG Y, Li B, Shi H, Yu H, et al
    Added value of SPECT/spiral CT versus SPECT or CT alone in diagnosing solitary skeletal lesions.
    Nuklearmedizin. 2017;56.
    PubMed     Text format     Abstract available


    June 2017
  9. LINDNER O, Bengel F, Burchert W, Dorr R, et al
    [Myokard-Perfusions-SPECT. Myocardial perfusion SPECT - Update S1 guideline].
    Nuklearmedizin. 2017;56.
    PubMed     Text format     Abstract available


    May 2017
  10. LEE JW, Park JS, Park KB, Yoo GH, et al
    Prediction of renal cortical defect and scar using neutrophil-to-lymphocyte ratio in children with febrile urinary tract infection.
    Nuklearmedizin. 2017 May 10. doi: 10.3413/Nukmed-0878.
    PubMed     Text format     Abstract available


    April 2017
  11. LUTJE S, Cohnen J, Gomez B, Gruneisen J, et al
    Integrated 68Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer.
    Nuklearmedizin. 2017 Apr 12. doi: 10.3413/Nukmed-0850.
    PubMed     Text format     Abstract available


    March 2017
  12. HELLWIG D, Marienhagen J, Menhart K, Grosse J, et al
    [Nuclear Medicine in Germany. Updated key data and trends from official statistics].
    Nuklearmedizin. 2017 Mar 7. doi: 10.3413/Nukmed-0880.
    PubMed     Text format     Abstract available


    February 2017
  13. GENSEKE P, Rogasch JM, Steffen IG, Neumann G, et al
    Detection of obstructive uropathy and assessment of differential renal function using two functional magnetic resonance urography tools. A comparison with diuretic renal scintigraphy in infants and children.
    Nuklearmedizin. 2017;56:39-46.
    PubMed     Text format     Abstract available


  14. TROGRLIC M, Tezak S
    Incremental value of 99mTc-HYNIC-TOC SPECT/CT over whole-body planar scintigraphy and SPECT in patients with neuroendocrine tumours.
    Nuklearmedizin. 2017 Feb 6. doi: 10.3413/Nukmed-0851.
    PubMed     Text format     Abstract available


  15. LAWAL I, Lengana T, Ololade K, Boshomane T, et al
    18F-FDG PET/CT in the detection of asymptomatic malignant melanoma recurrence.
    Nuklearmedizin. 2017 Feb 3. doi: 10.3413/Nukmed-0864.
    PubMed     Text format     Abstract available


    January 2017
  16. BRAUER A, Rahbar K, Konnert J, Bogemann M, et al
    Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma.
    Nuklearmedizin. 2017 Jan 11. doi: 10.3413/Nukmed-0846.
    PubMed     Text format     Abstract available


    December 2016
  17. FROLICH A, Schwarze I, Neumann C
    Polymyalgia rheumatica detected by SPECT/CT using 99mTc-labeled monoclonal antibody Fab'-fragments.
    Nuklearmedizin. 2016 Dec 22. doi: 10.3413/Nukmed-0849.
    PubMed     Text format    


  18. DIRLIK SERIM B, Vatankulu B, Halac M, Dikici S, et al
    Metastatic epithelioid sarcoma revealed with 18F-FDG PET/CT imaging.
    Nuklearmedizin. 2016;55:N62-N63.
    PubMed     Text format    


  19. BEHRENDT F, Krohn T, Mottaghy F, Verburg FA, et al
    [68Ga]PSMA-HBED-CC PET/CT to differentiate between diffuse bone metastases of prostate cancer and osteopoikilosis.
    Nuklearmedizin. 2016;55:N64-N65.
    PubMed     Text format    


  20. DIETLEIN M, Drzezga A
    [Der hoch-normale fT4-Spiegel ist mit Vorhofflimmern assoziiert. Neue Daten erganzen die DGN-Handlungsempfehlung zur Radioiodtherapie].
    Nuklearmedizin. 2016;55:210-212.
    PubMed     Text format    


  21. DIETLEIN M, Grunwald F, Schmidt M, Schneider P, et al
    [Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].
    Nuklearmedizin. 2016;55:213-220.
    PubMed     Text format     Abstract available


  22. FROLICH A, Knoll G, Bahre M, Neumann C, et al
    Diagnosis of chronic osteomyelitis by combined 99mTc-bone and 99mTc-anti-granulocyte scintigraphy.
    Nuklearmedizin. 2016;55:N60-N61.
    PubMed     Text format    


  23. ILHAN H, Mustafa M, Bartenstein P, Kuwert T, et al
    Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study.
    Nuklearmedizin. 2016;55:221-227.
    PubMed     Text format     Abstract available


  24. LINDNER O, Burchert W, Schafer W, Hacker M, et al
    Myocardial perfusion SPECT 2015 in Germany. Results of the 7th survey.
    Nuklearmedizin. 2016.
    PubMed     Text format     Abstract available


    November 2016
  25. HARDIANSYAH D, Guo W, Attarwala AA, Kletting P, et al
    Treatment planning in PRRT based on simulated PET data and a PBPK model. Determination of accuracy using a PET noise model.
    Nuklearmedizin. 2016.
    PubMed     Text format     Abstract available


    September 2016
  26. SEIFERT P, Konig V, Hofmann GO, Freesmeyer M, et al
    Devitalized bone in a multi-fragment femoral shaft fracture detected by (18)F-NaF PET-CT.
    Nuklearmedizin. 2016;55:N52-3.
    PubMed     Text format    


  27. CHROUSTOVA D, Bloomfield M, Benes J Jr, Trnka J, et al
    The role of (18)F-FDG PET/CT in diagnosis and therapeutic approach in small child with MSMD.
    Nuklearmedizin. 2016;55:N49-51.
    PubMed     Text format    


  28. WANG G, Liu Y, He F
    Primary lymphoma involving cranial nerves and cauda equina detected by (18)F-FDG PET/CT and MRI.
    Nuklearmedizin. 2016;55:N46-8.
    PubMed     Text format    


  29. POPPEL TD, Andreeff M, Becherer A, Bockisch A, et al
    [Therapy of bone metastases with radium-223. German guidelines].
    Nuklearmedizin. 2016;55:177-86.
    PubMed     Text format     Abstract available


  30. BOUTER C, Braune I, Meller B, Sahlmann C, et al
    18F-FDG-PET/CT in unexplained elevated inflammatory markers. Joining entities.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


    August 2016
  31. AL-IBRAHEEM A, Al-Hussaini M, AlSharif A, Abdulelah H, et al
    Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours.
    Nuklearmedizin. 2016;55:N34-5.
    PubMed     Text format    


  32. LI B, Zhang M, Jin J
    Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas.
    Nuklearmedizin. 2016;55:N32-3.
    PubMed     Text format    


  33. SCHUTZE C, Knoop BO, Vehrenkamp I, Rudolf F, et al
    [Constancy check of system linearity for dose calibrators. Effect of molybdenum impurities at high start activities of 99mTc].
    Nuklearmedizin. 2016;55:172-5.
    PubMed     Text format     Abstract available


  34. KIM SJ, Choi JY, Lee JH, Hyun SH, et al
    Incidental 99mTc MDP uptake in the intestines and intravenous CT contrast.
    Nuklearmedizin. 2016;55:166-71.
    PubMed     Text format     Abstract available


    July 2016
  35. LANGE R, Overbeek F, de Klerk JM, Pasker-de Jong PC, et al
    Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  36. ILIC V, Dunet V, Le Pape A, Buchs M, et al
    SPECT/CT study of bronchial deposition of inhaled particles. A human aerosol vaccination model against HPV.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  37. RANGE FT, Kies P, Schafers KP, Breithardt G, et al
    Sex differences in absolute myocardial perfusion. Non-invasive H215O-PET in young healthy adults.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


    June 2016
  38. FENDLER WP, Kratochwil C, Ahmadzadehfar H, Rahbar K, et al
    [177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer].
    Nuklearmedizin. 2016;55:123-8.
    PubMed     Text format     Abstract available


  39. DIETLEIN M, Eschner W, Grunwald F, Lassmann M, et al
    [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
    Nuklearmedizin. 2016;55:77-89.
    PubMed     Text format     Abstract available


    April 2016
  40. HUNG MC, Hwang JJ
    Trends in the utilization of nuclear medicine and radiopharmaceuticals in an aging population.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  41. BARTHEL H, Meyer PT, Drzezga A, Bartenstein P, et al
    [German Society of Nuclear Medicine procedure guideline on beta-amyloid brain PET imaging].
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  42. STOLLFUSS JC, Freudenberg LS, Wieder H
    99mTc-DPD SPECT/CT for localisation of inflammatory and chronic osteoarthritis of the foot and ankle. Comparison with planar imaging and SPECT as a clinical adjunct in radiosynovectomy.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  43. VAN BINNEBEEK S, Koole M, Terwinghe C, Baete K, et al
    Dynamic 68Ga-DOTATOC PET/CT and static image in NET patients. Correlation of parameters during PRRT.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  44. CERNY I, Prasek J, Kasparkova H
    Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  45. HENDRIKX G, Bauwens M, Wierts R, Mottaghy FM, et al
    Left ventricular function measurements in a mouse myocardial infarction model. Comparison between 3D-echocardiography and ECG-gated SPECT.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


    February 2016
  46. FERRARI C, Niccoli Asabella A, Altini C, Rubini G, et al
    A rare case of osteopetrosis mimicking osteosarcoma: 18F-FDG PET/CT findings in an unexpected diagnosis.
    Nuklearmedizin. 2016;55:N1-3.
    PubMed     Text format    


  47. LEE JY, Choi JY, Heo JH, Han J, et al
    Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
    Nuklearmedizin. 2016;55:7-14.
    PubMed     Text format     Abstract available


  48. RUHLMANN M, Binse I, Bockisch A, Rosenbaum-Krumme SJ, et al
    Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


    January 2016
  49. KNIE B, Plotkin M, Zschieschang P, Prasad V, et al
    A family with pheochromocytoma-paraganglioma inherited tumour syndrome. Serial 18F-DOPA PET/CT investigations.
    Nuklearmedizin. 2016;55.
    PubMed     Text format     Abstract available


  50. SINGH G, Gott MD, Pietzsch HJ, Stephan H, et al
    Nuclear and optical dual-labelled imaging agents. Design and challenges.
    Nuklearmedizin. 2016;55:41-50.
    PubMed     Text format     Abstract available


    December 2015
  51. WELZ F, Sanders JC, Kuwert T, Maler J, et al
    Absolute SPECT/CT quantification of cerebral uptake of 99mTc-HMPAO for patients with neurocognitive disorders.
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available


  52. HOFFMEISTER K, Preuss R, Weise R, Burchert W, et al
    The effect of beta blocker withdrawal on myocardial SPECT modeled from adenosine 13N-ammonia PET.
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available


  53. MULLER FH, Farahati J, Muller AG, Gillman E, et al
    Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
    Nuklearmedizin. 2015;55.
    PubMed     Text format     Abstract available


    November 2015
  54. ZHANG Y, Shi H, Li B, Cai L, et al
    The added value of SPECT/spiral CT in patients with equivocal bony metastasis from hepatocellular carcinoma.
    Nuklearmedizin. 2015;54:255-61.
    PubMed     Text format     Abstract available


    January 2015
  55. BRANDSTATTER W, Hatzl M, Weis S, Javor A, et al
    Successful resection of TSH-secreting pituitary adenoma demonstrated by serial 99mTc-scintigraphy.
    Nuklearmedizin. 2015;54:N23-4.
    PubMed     Text format    


  56. KREISSL MC, Fassnacht M, Mueller SP
    Systemic treatment of advanced differentiated and medullary thyroid cancer. Overview and practical aspects.
    Nuklearmedizin. 2015;54:88-93.
    PubMed     Text format     Abstract available


  57. LUSTER M
    [Thyroid into the focus of attention].
    Nuklearmedizin. 2015;54:75-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: